Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

Phase 2

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Sofosbuvir/Velpatasvir/Voxilaprevir

First Posted Date: 2016-04-20

Last Posted Date: 2022-03-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 77

Registration Number: NCT02745535

Locations: 🇺🇸
Institute of Human Virology, Baltimore, Maryland, United States

Bronchial Mapping (GCC 1635)

Terminated

Conditions: Thoracic Cancer

First Posted Date: 2016-04-20

Last Posted Date: 2025-05-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 23

Registration Number: NCT02745548

Locations: 🇺🇸
Ummc Msgcc, Baltimore, Maryland, United States

1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer

Terminated

Conditions: Healthy Volunteers

Interventions: Other: Phlebotomy - Blood sampling for GP88 at MM
Procedure: SOC Tissue biopsy

First Posted Date: 2016-03-07

Last Posted Date: 2019-11-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 417

Registration Number: NCT02700776

Locations: 🇺🇸
University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
Baltimore Washington Medical Center, Glen Burnie, Maryland, United States

Loop Drainage: Effectiveness in Treating Cutaneous Abscesses

Not Applicable

Terminated

Conditions: Abscess of Skin and/or Subcutaneous Tissue

Interventions: Procedure: Traditional Incision and Drainage.
Procedure: Loop drainage

First Posted Date: 2016-03-03

Last Posted Date: 2022-01-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 5

Registration Number: NCT02697279

Locations: 🇺🇸
University of Maryland Medical Systems, Baltimore, Maryland, United States

Lung SBRT Motion Management (GCC 1619)

Terminated

Conditions: Lung Cancer

First Posted Date: 2016-03-01

Last Posted Date: 2024-05-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 40

Registration Number: NCT02695680

Locations: 🇺🇸
Ummc Msgcc, Baltimore, Maryland, United States
🇺🇸
Upper Chesapeake Health, Bel Air, Maryland, United States

Dose Response of Epinephrine

Early Phase 1

Recruiting

Conditions: Diabetes Complications

Interventions: Other: Saline infusion
Drug: Epinephrine

First Posted Date: 2016-02-26

Last Posted Date: 2024-03-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 32

Registration Number: NCT02692313

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Cardiac MRI Biomarker Testing (GCC 1618)

Terminated

Conditions: Breast Cancer
Mesothelioma
Lung Cancer (Non-Small Cell)
Thymic Cancer
Thoracic Cancer

Interventions: Other: Complete Cardiac Magnetic Resonance Imaging (MRI)

First Posted Date: 2016-02-23

Last Posted Date: 2022-10-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 6

Registration Number: NCT02688166

Locations: 🇺🇸
Ummc Msgccc, Baltimore, Maryland, United States

Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women

Phase 2

Completed

Conditions: Non-anemic Iron Deficiency

Interventions: Dietary Supplement: Blood Builder®/Iron Response®

First Posted Date: 2016-02-17

Last Posted Date: 2019-08-16

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 23

Registration Number: NCT02683369

Locations: 🇺🇸
Center for Integrative Medicine University of Maryland, Baltimore, Maryland, United States

Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

Phase 2

Withdrawn

Conditions: Multiple Myeloma
Hematopoietic Stem Cells
Lymphoma
Bone Marrow Transplantation

Interventions: Drug: Neupogen
Procedure: Hyperbaric oxygen therapy
Drug: Plerixafor

First Posted Date: 2016-02-17

Last Posted Date: 2019-12-11

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT02682953

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms

Completed

Conditions: Intracranial Aneurysms

First Posted Date: 2016-01-18

Last Posted Date: 2022-03-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 100

Registration Number: NCT02657772

Locations: 🇺🇸
Christiana Care Health System, Newark, Delaware, United States
🇺🇸
WellStar Research Institute, Marietta, Georgia, United States
🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy